Logindo Samudramakmur Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Logindo Samudramakmur Tbk. trades at Rp101 (market cap 574.16B, 12.07M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp248 (market cap 167.37B, 96.7K 24h volume). The key difference: Logindo Samudramakmur Tbk. is far larger — about 3.4× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Logindo Samudramakmur Tbk. is more actively traded (12.07M versus 96.7K). Which is the better fit depends on your goals.
| LEAD | OBAT | |
|---|---|---|
Market Cap | 574.16B | 167.37B |
Volume | 12.07M | 96.7K |
Lot | 120.69K | 967 |
Turnover | 1.2B | 23.82M |
Average Price | 99.77 | 246.34 |
Value | 1.2B | 23.82M |
Indicative Equilibrium Price | 101 | 248 |
Indicative Equilibrium Volume | 3.23K | 41 |
Trailing returns across standard periods
Latest headlines on both assets
PT Logindo Samudramakmur Tbk (the Company) is domiciled and was established in Jakarta, Indonesia based on Notarial Deed No. 55 of Nurul Hidajati Handoko, SH., Public Notary in Jakarta dated August 23, 1995. The company currently owns and operates a fleet of 58 offshore support with various types and functions. The company has a portfolio of customers ranging from mining oil and gas local to multinational.
Read more on LEAD →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →